Kasan Insight :: Korea IP Law Blog

Korea IP Law and Practice on Patent, Design, Trademark, Copyright, Trade Secrets and Unfair Competition

Roche v. Celltrion re: Herceptin Patent Infringement Lawsuit over Biosimilar Herzuma

›
Celltrion, a Korean company developed a biosimilar Herzuma to Herceptin (trastuzumab) and obtained market approval (MA) for a biosimilar He...

Menarini’s Priligy (Dapoxetine HCl) Use Patent held Not Valid as being Obvious

›
Menarini launched Priligy in Korea. Dapoxetine HCl is the active ingredient in Priligy tablets. Korean patent No. 719, 977 covers the brand...

EV Battery Patent Infringement Lawsuits – LG Chem vs. SK Innovation

›
Two Korean companies, LG Chem and SK Innovation are major suppliers for EV batteries to top 10 global car makers including GM, VW, Renault,...

Low Dose Entecavir Formulation in Korean Patent held as being Obvious by the IPT of KIPO

›
Entecavir is the active ingredient in Baraclude tablets of BMS. The drug has been sold for the treatment of chronic hepatitis B virus infe...

Canon v. Baiksan OPC – Patent Owner Canon Awarded US$14 million Damage for Patent Infringement in Korea

›
The patentee Canon filed many lawsuits against Korean companies. Canon alleged that local companies’ manufacturing and marketing of several...
‹
›
Home
View web version
Powered by Blogger.